Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

European Biotechs Enter the IPO Big League

Genmab's NASDAQ Debut Biggest of 2019

Nov 14 2019

• By William Masters

New_York — The Nasdaq is the prime destination for US and European biotechs

Related Content

Finance Watch: BioNTech, Vir Launch IPOs But Take US Offerings To Market At A Discount

Oct 11 2019

Interview: Why Europe’s Biotech ‘Prime Time’ Is Now

Oct 22 2019

Autolus Faces Life After Woodford With New Czech Backer

Sep 18 2019

Related Companies

Genfit SA

Innate Pharma S.A.

Bicycle Therapeutics, plc

Autolus Therapeutics plc

Orchard Therapeutics Limited

Gilead Sciences, Inc.

Galapagos NV

ADC Therapeutics SA

BioNTech SE

Genmab A/S

Johnson & Johnson

Novartis AG

MorphoSys AG

Additional Topics

Europe Commercial Companies Financing Innovation StartUps and SMEs Cancer Immune Disorders BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window